Study of Abiraterone Acetate, Atezolizumab, Lupron, and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Condition: Metastatic Prostate Cancer Interventions: Drug: Atezolizumab; Drug: Abiraterone; Drug: Prednisone; Drug: Lupron Sponsors: Memorial Sloan Kettering Cancer Center; Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Hormones | Prednisone | Prostate Cancer | Radiation Therapy | Research | Study